Singular Genomics Systems, Inc.
NASDAQ: OMIC0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Andrew Spaventa
- Employees
- 255
- Headquarters
- La Jolla, United States
- IPO year
- 2021
- Market cap
- $50.8M
- Website
- https://singulargenomics.com
Loading OMIC…
Loading profile data…Frequently asked questions about OMIC
What does Singular Genomics Systems, Inc. (OMIC) do?
Singular Genomics Systems, Inc. is a life science technology firm focused on creating advanced next-generation sequencing and multiomics solutions. The company aims to provide researchers and clinicians with innovative tools to accelerate scientific discovery and medical advancements. Among its core products is the G4 Instrument, a compact next-...
Where does OMIC trade?
Singular Genomics Systems, Inc. (OMIC) trades on the NASDAQ Global Select.
What sector is OMIC in?
Singular Genomics Systems, Inc. (OMIC) operates in the Healthcare sector, specifically in the Medical - Instruments & Supplies industry.
Who is the CEO of Singular Genomics Systems, Inc.?
Andrew Spaventa is the chief executive officer of Singular Genomics Systems, Inc. (OMIC).
Where is Singular Genomics Systems, Inc. headquartered?
Singular Genomics Systems, Inc. is headquartered in United States.
Does OMIC pay a dividend?
Singular Genomics Systems, Inc. (OMIC) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did OMIC go public?
Singular Genomics Systems, Inc. (OMIC) completed its initial public offering in 2021.